Pharmaceutical Third Party Manufacturing in India: Complete Business Guide (2025–2026)
Categories
Tags
You May Also Like
Introduction
Building a pharmaceutical brand in India no longer requires owning a manufacturing plant. Pharmaceutical third party manufacturing has emerged as the most accessible, cost-efficient, and strategically powerful model for launching and scaling a pharma business — and it has transformed India’s healthcare industry from within.
The Indian pharmaceutical market is expected to reach a value of ₹4,71,295 crores by 2026, and third-party manufacturing is one of the primary engines driving this growth. Whether you are a new entrepreneur entering the healthcare sector, a doctor wanting to launch your own medicine brand, a distributor looking to expand your product portfolio, or an international importer seeking quality Indian medicines — third party manufacturing gives you access to world-class production without the crore-level capital investment of building your own facility.
This guide covers everything you need to know about pharmaceutical third party manufacturing in India — how it works, who it is for, what documents are required, how to evaluate a manufacturing partner, and why Salvavidas Pharmaceutical Pvt. Ltd. is the trusted choice for businesses building their pharma brand.
What Is Pharmaceutical Third Party Manufacturing?
Pharmaceutical third party manufacturing in India is a contractual arrangement in which a pharmaceutical company with licensed manufacturing facilities produces medicines, nutraceuticals, or healthcare products for a third party — typically a brand, distributor, or marketing company that does not own its own manufacturing unit.
In simple terms:
- You own the product brand, marketing rights, and distribution network
- The manufacturer owns the facility, equipment, licenses, and technical expertise
- Together, you bring quality pharmaceutical products to market faster and at significantly lower cost than either party could alone
This approach is also known as contract manufacturing and has become a common practice in India, where the pharmaceutical landscape is highly competitive and innovation-driven.
Who Is Pharmaceutical Third Party Manufacturing For?
Third party pharma manufacturing is the right model for a wide range of business profiles:
| Business Type | How Third Party Manufacturing Helps |
|---|---|
| New Pharma Entrepreneurs | Launch a medicine brand without factory investment |
| PCD Franchise Businesses | Expand product range without manufacturing overheads |
| Doctors & Healthcare Professionals | Create proprietary medicine brands under your name |
| Distributors & Wholesalers | Add private-label products to your portfolio |
| International Importers | Source WHO-GMP certified medicines under your brand |
| Established Pharma Brands | Outsource overflow production or new product lines |
| Export-Focused Businesses | Access certified Indian manufacturing for global supply |
Large pharmaceutical manufacturers require additional capacity for in-demand medications. Businesses that offer marketing services aim to serve various markets. Healthcare practitioners, such as doctors or pharmacists, want to establish their own medical labels. Export businesses that appeal to the global market with Indian generic drugs. All of these profiles benefit directly from the third party model.
How Does Pharmaceutical Third Party Manufacturing Work? Step-by-Step Process
The pharma third-party manufacturing process involves several critical steps. Here is a clear, practical walkthrough:
Step 1: Product Selection
Start with high-demand, low-competition products. Decide which medicines you want to market — including composition, dosage form (tablet, capsule, syrup, injection, cream), pack size, and target market. Research therapeutic categories where demand is strong and supply gaps exist.
Step 2: Choose Your Manufacturing Partner
Choosing one out of the list of third party manufacturing pharma companies in India is a very critical business decision. After all, it will ultimately determine the quality of your product and expedite market entry. In this respect, one should give priority only to WHO-GMP-certified facilities that have an established track record.
Step 3: Submit Required Documents
Both parties exchange business and product documentation — including drug licenses, GST registration, marketing authorizations, and product specifications — to formalize the manufacturing relationship.
Step 4: Sign Manufacturing Agreement
The U.S. Congress passed the “BIOSECURE Act” restricting federal contracts with certain foreign biotech firms, prompting U.S. pharma companies to shift contracts from China to India — creating a massive tA legal manufacturing agreement is drafted and signed between the company and the third party pharmaceutical manufacturer that outlines the rights and responsibilities of both the parties involved in the third party manufacturing model. Key terms include pricing, MOQs, timelines, packaging specifications, and confidentiality clauses.ailwind for Indian CDMOs as “China Plus One” beneficiaries.
Step 5: Raw Material Procurement & Quality Testing
The manufacturer sources Active Pharmaceutical Ingredients (APIs) and excipients from approved vendors. In WHO-GMP certified plants, every raw material undergoes strict quality testing before being released for production.
Step 6: Manufacturing & In-Process Quality Checks
The product is manufactured under supervision and goes through multiple stages of quality testing. Batch Manufacturing Records (BMRs) are maintained throughout the production process.
Step 7: Finished Product Testing & Certificate of Analysis
The largest segment of India’s CDMO market, covering synthesis and production of Active Pharmaceutical Ingredients for generic and branded drug manufacturers worldwide. Small molecules exhibit clear dominance with a 67.2% share of the total India CDMO market in 2025.
Step 8: Packaging & Branding Under Your Label
Finished goods are packed under the company’s brand name and delivered to the designated location. Packaging design, foil printing, labeling, and carton artwork are typically provided by the client and executed by the manufacturer.
Step 9: Delivery & Distribution
Products are shipped to the client’s warehouse, distribution network, or directly to end buyers — depending on the agreed logistics arrangement.
Typical Timeline: It usually takes about 8–11 weeks, on average, from the beginning of the documentation to a finished product. Timelines vary based on product complexity and documentation readiness.
Key Benefits of Pharmaceutical Third Party Manufacturing
Third-party manufacturing offers several significant advantages for pharmaceutical companies. By outsourcing production, companies can tap into the expertise and advanced facilities of established manufacturers, which can result in substantial cost savings and improved efficiency.
1. No Factory Investment Required
You do not have to spend crores of rupees on land acquisition, building development, and skilled manpower. Rather, you can employ the knowledge of the best pharma companies that have already been optimizing their supply chain. This way, you can easily turn your high capital expenditure into operational expenses.
2. Faster Market Entry
Launch products quickly without infrastructure delays. Leveraging a manufacturer’s established, validated production lines significantly compresses your time-to-market compared to building your own facility
3. Focus on Marketing & Sales
The best third party pharma manufacturing companies in India can focus more effectively on their marketing and sales activities after hiring a specialized manufacturer, as it is responsible for every step of the entire pharma production process.
4. Access to Certified Quality Standards
Reputed third-party manufacturers follow strict quality control processes, ensuring that all products meet national and international guidelines like WHO-GMP and ISO standards.
5. Flexible Scalability
Businesses can easily scale their product line based on market demand, without worrying about production constraints or additional infrastructure.
6. Cost Efficiency at Scale
Manufacturing costs in India are 30–40% lower than in Western countries, making Indian-manufactured medicines highly competitive globally. Third party clients benefit directly from these cost advantages via the manufacturer’s economies of scale.
7. Wide Dosage Form Flexibility
Indian manufacturers can produce tablets, capsules, syrups, injectables, eye drops, creams, ointments, nutraceuticals, ayurvedic formulations, and more — all under one roof.
8. Regulatory Compliance Handled
The pharma production company takes care of all complexities related to regulatory issues, changes to Schedule M, and more. Consequently, partnering with third party pharma manufacturers allows you to focus purely on market expansion.
Documents Required for Pharmaceutical Third Party Manufacturing
To initiate a third party manufacturing arrangement in India, the following documents are typically required from the client (marketing company):
Business Documents:
*Drug License (for marketing and distribution of medicines)
*GST Registration Certificate
*PAN Card
*Aadhar Card / Voter ID of authorized signatory
*Memorandum & Articles of Association or Partnership Deed
Product-Specific Documents:
*Product list with complete compositions and strengths
*Packaging specifications (pack size, strip/bottle/blister type)
*Brand name and label artwork
*Target market details (domestic / export)
For Export Orders:
*Import Export Code (IEC) — from DGFT
*Certificate of Pharmaceutical Product (COPP) — if required for overseas registration
*Free Sale Certificate — if required by destination country
The manufacturer typically handles the manufacturing license, batch manufacturing records (BMR), CoA, and all production-side documentation.
How to Choose the Right Pharmaceutical Third Party Manufacturer
Your manufacturing partner directly determines the quality of every product that reaches your customers. Here is a practical checklist for evaluation:
WHO-GMP or ISO Certification
The absolute minimum quality standard. Verify the certificate is current and issued by the appropriate regulatory authority.
Product Range Compatibility
Confirm the manufacturer produces the specific dosage forms you need — tablets, capsules, syrups, injectables, creams — in your therapeutic category.
Regulatory Track Record
Ask about regulatory inspection history. A facility with a consistent record of compliance is a far safer partner than one with recent observations or violations.
Quality Control Infrastructure
In-house QC/QA labs, validated analytical methods, and documented testing protocols are non-negotiable for any serious third party manufacturer.
Minimum Order Quantities (MOQs)
Normally, it takes 30 to 60 days, which is determined by the product’s complexity and the documentation’s status. Confirm MOQs are workable for your initial launch volumes — especially important for new businesses.
Packaging & Branding Support
Check whether the manufacturer supports custom packaging, private label printing, and artwork development — or whether you need to source these separately.
Pricing Transparency
Request itemized quotations covering raw materials, manufacturing charges, quality testing, and packaging. Avoid manufacturers who are vague about cost components.
Communication & Responsiveness
A manufacturer who responds quickly, provides clear answers, and assigns a dedicated point of contact is significantly easier to work with over the long term.
IP & Confidentiality Protection
Ensure the manufacturer has standard NDAs and manufacturing agreements that clearly protect your formulation, brand name, and business information.
Pharmaceutical Third Party Manufacturing: Investment Overview
One of the most compelling aspects of the third party model is how accessible it is:
| Scale of Operation | Estimated Starting Investment |
|---|---|
| Small product range (5–10 products) | ₹2,00,000 – ₹5,00,000 |
| Medium range (10–25 products) | ₹5,00,000 – ₹15,00,000 |
| Large range (25+ products, export) | ₹15,00,000+ |
The initial investment for a limited product range in 2026 would start from around ₹2,00,000 to ₹5,00,000. This is a fraction of the crore-level capital required to build your own GMP-compliant manufacturing facility.
India's Third Party Pharma Manufacturing Market: Why Now Is the Right Time
The global pharma contract manufacturing market, valued at USD 129.19 billion in 2024, is expected to reach USD 224.51 billion in 2030. The Indian market is growing as well, from USD 23.22 billion in 2023 to nearly USD 40 billion in 2030.
The demand for generic medicines and affordable healthcare is growing both in India and globally. This has created ample opportunities for pharmaceutical companies to adopt the third-party manufacturing model and expand rapidly without heavy investments.
Key drivers making now the ideal time to enter pharmaceutical third party manufacturing:
*Patent cliff opportunities — Hundreds of blockbuster drugs are losing patent protection, opening mass generic manufacturing demand
*Rising domestic healthcare spending — India’s growing middle class is driving healthcare consumption
*Export opportunity — India exports medicines to 200+ countries, and third party manufacturers increasingly support export brands
*Government PLI support — The government has committed more than ₹15,000 crore to enhance domestic pharmaceutical manufacturing
*Evolving consumer trust in generics — Growing acceptance of generic medicines at all income levels
Top Pharmaceutical Third Party Manufacturers in India (2025–2026)
1. Salvavidas Pharmaceutical Pvt. Ltd. — Surat, Gujarat ⭐ Recommended
Salvavidas Pharmaceutical Pvt. Ltd. is a WHO-GMP certified pharmaceutical manufacturer in Surat, Gujarat — one of India’s most established pharmaceutical manufacturing hubs. For businesses looking to build their brand through third party manufacturing, Salvavidas offers a dependable combination of certified quality, broad product range, and a genuinely partner-focused approach.
Why Pharma Brands Choose Salvavidas for Third Party Manufacturing:
| Feature | Details |
|---|---|
| Certification | WHO-GMP Certified |
| Product Range | Formulations, APIs, Injectables, Intermediates |
| Therapeutic Areas | Anti-infective, Cardiovascular, Oncology, Neurology & more |
| Markets | Domestic + Export (Asia, Africa, Europe, Middle East) |
| Documentation | CoA, COPP, Free Sale Certificate, GMP Certificates |
| Private Labeling | Available — under your brand name |
| MOQ Flexibility | Client-friendly for new product launches |
| Support | Regulatory documentation support for domestic & export |
| Communication | Responsive, transparent, dedicated team |
Unlike large manufacturers where smaller clients can get lost in the crowd, Salvavidas brings a focused, attentive approach to every manufacturing partnership — which is why pharma brands, distributors, and international importers return for repeat business.
🏭 Ready to launch your pharma brand through third party manufacturing? Contact Salvavidas Pharmaceutical Pvt. Ltd. for product list, pricing, MOQ details, and documentation support. 📧 info@salvavidas.com
2. Akums Drugs & Pharmaceuticals — Haridwar, Uttarakhand
A leading CDMO with 12 plants and recent European GMP approvals, Akums is one of India’s largest third party pharma manufacturers by volume, covering tablets, capsules, injectables, and liquids across multiple therapeutic areas.
3. JM Laboratories — Solan, Himachal Pradesh
JM Laboratories stands apart in its commitment towards cost-effective and quality production solutions. The company extends all-around support through custom formulation and advanced R&D services and their facilities are GMP-compliant with a wide array of DCGI-approved products.
4. Lifevision Healthcare — India
WHO-GMP and ISO certified with complete third-party manufacturing services from formulation to packaging. Tailored solutions and the ability to scale for startups, marketers, and established brands with clear pricing structures and punctual delivery.
5. Zydus Lifesciences — Ahmedabad, Gujarat
A well-known pharmaceutical firm that offers third-party facility services for a lot of formulations, including biologics and biosimilars, with an advanced manufacturing facility focusing on innovation and a wide therapeutic range including oncology, dermatology, and cardiology.
Frequently Asked Questions (FAQs)
Q1. What is the difference between third party manufacturing and PCD pharma franchise?
In third party manufacturing, you get medicines produced under your own brand name by a certified manufacturer — you own the brand. In a PCD (Propaganda Cum Distribution) franchise, you market and distribute medicines under the franchisor’s established brand. Third party manufacturing gives you full brand ownership; PCD franchising leverages an existing brand’s recognition.
Q2. Do I need a drug license to start a third party pharma manufacturing business?
Yes. As the marketing company, you need a Drug License for the sale and marketing of medicines, a GST registration, and an IEC (Import Export Code) if you plan to export. The manufacturing license stays with the third party manufacturer.
Q3. Can I do pharmaceutical third party manufacturing for export?
Absolutely. Many Indian third party manufacturers, including Salvavidas Pharmaceutical, produce export-grade products with full documentation — CoA, COPP, Free Sale Certificate — enabling your brand to be registered and sold in international markets.
Q4. What is the minimum order quantity (MOQ) in third party pharma manufacturing?
MOQs vary by product and manufacturer. Typically, smaller runs of 1,000–5,000 units per SKU are feasible for initial launches, though MOQs increase for more complex dosage forms like sterile injectables.
Q5. How long does the entire process take from agreement to delivery?
It usually takes about 8–11 weeks, on average, from the beginning of the documentation to a finished product. Simple products with established formulations and ready packaging artwork can move faster; new formulation development extends the timeline.
Q6. Is pharmaceutical third party manufacturing profitable?
Yes — significantly. By eliminating factory capital costs and focusing resources on marketing and distribution, businesses consistently achieve strong margins. The key is choosing quality-certified manufacturers to protect your brand’s reputation in the market.
Conclusion
3rd Party Manufacturing has revolutionized how pharmaceutical companies operate in India. It provides a flexible, scalable, and cost-effective way to deliver quality healthcare products to the market. Whether you’re a startup looking to launch your first product or an established company planning to expand your portfolio, this model offers unmatched advantages.
The right third party manufacturing partner is not just a production facility — it is the foundation of your pharmaceutical brand’s quality, compliance, and reputation. Salvavidas Pharmaceutical Pvt. Ltd. brings WHO-GMP certified manufacturing, a comprehensive product portfolio, and a partnership approach that supports your business at every stage — from initial product selection to final delivery under your brand.
Start building your pharmaceutical brand today. Partner with Salvavidas Pharmaceutical Pvt. Ltd. — your trusted pharmaceutical third party manufacturing partner in India.